End-of-day quote
Shanghai S.E.
18:00:00 2024-05-20 EDT
|
5-day change
|
1st Jan Change
|
17.13
CNY
|
-3.00%
|
|
-0.46%
|
-18.82%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,417
|
2,035
|
1,556
|
1,671
|
Enterprise Value (EV)
1 |
2,037
|
1,604
|
1,195
|
1,243
|
P/E ratio
|
55.9
x
|
49.9
x
|
36.6
x
|
36.4
x
|
Yield
|
0.66%
|
0.79%
|
1.29%
|
-
|
Capitalization / Revenue
|
14.8
x
|
9.52
x
|
6.71
x
|
6.59
x
|
EV / Revenue
|
12.5
x
|
7.51
x
|
5.15
x
|
4.9
x
|
EV / EBITDA
|
56.2
x
|
45.2
x
|
29
x
|
30.6
x
|
EV / FCF
|
109
x
|
35.5
x
|
-166
x
|
25
x
|
FCF Yield
|
0.92%
|
2.82%
|
-0.6%
|
4%
|
Price to Book
|
5.19
x
|
3.97
x
|
2.98
x
|
2.92
x
|
Nbr of stocks (in thousands)
|
80,000
|
80,000
|
80,246
|
79,206
|
Reference price
2 |
30.21
|
25.44
|
19.39
|
21.10
|
Announcement Date
|
21-04-29
|
22-04-28
|
23-04-25
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
119
|
172.8
|
163.3
|
213.7
|
232
|
253.6
|
EBITDA
1 |
26.17
|
49.28
|
36.23
|
35.5
|
41.25
|
40.59
|
EBIT
1 |
22.46
|
43.87
|
29.82
|
28.41
|
33.27
|
31.66
|
Operating Margin
|
18.87%
|
25.4%
|
18.26%
|
13.29%
|
14.34%
|
12.48%
|
Earnings before Tax (EBT)
1 |
27.16
|
48.6
|
40.2
|
46.09
|
46.08
|
47.95
|
Net income
1 |
23.13
|
42.01
|
34.95
|
41.42
|
43.2
|
47.31
|
Net margin
|
19.43%
|
24.32%
|
21.4%
|
19.38%
|
18.62%
|
18.65%
|
EPS
|
-
|
0.7000
|
0.5400
|
0.5100
|
0.5300
|
0.5800
|
Free Cash Flow
1 |
0.8737
|
7.086
|
18.77
|
45.17
|
-7.193
|
49.71
|
FCF margin
|
0.73%
|
4.1%
|
11.49%
|
21.13%
|
-3.1%
|
19.6%
|
FCF Conversion (EBITDA)
|
3.34%
|
14.38%
|
51.81%
|
127.24%
|
-
|
122.47%
|
FCF Conversion (Net income)
|
3.78%
|
16.87%
|
53.7%
|
109.06%
|
-
|
105.06%
|
Dividend per Share
|
-
|
-
|
0.2000
|
0.2000
|
0.2500
|
-
|
Announcement Date
|
20-09-09
|
20-09-09
|
21-04-29
|
22-04-28
|
23-04-25
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
13
|
19
|
380
|
431
|
361
|
428
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
0.87
|
7.09
|
18.8
|
45.2
|
-7.19
|
49.7
|
ROE (net income / shareholders' equity)
|
28.4%
|
44.2%
|
12.2%
|
8.47%
|
8.47%
|
8.76%
|
ROA (Net income/ Total Assets)
|
13%
|
22.7%
|
6.11%
|
3.45%
|
3.82%
|
3.38%
|
Assets
1 |
177.6
|
185.3
|
572.1
|
1,201
|
1,130
|
1,399
|
Book Value Per Share
2 |
1.400
|
1.790
|
5.820
|
6.400
|
6.510
|
7.230
|
Cash Flow per Share
2 |
0.3100
|
0.3100
|
1.580
|
0.9400
|
0.4200
|
2.670
|
Capex
1 |
20.8
|
9.41
|
7.29
|
9.21
|
47.7
|
18.4
|
Capex / Sales
|
17.46%
|
5.45%
|
4.46%
|
4.31%
|
20.54%
|
7.26%
|
Announcement Date
|
20-09-09
|
20-09-09
|
21-04-29
|
22-04-28
|
23-04-25
|
24-04-26
|
|
1st Jan change
|
Capi.
|
---|
| -18.82% | 193M | | +10.73% | 27.82B | | -33.38% | 3.11B | | +32.96% | 2.66B | | -18.17% | 2.45B | | +6.29% | 2.22B | | -3.27% | 2.05B | | +32.22% | 2.03B | | +31.89% | 1.35B | | +1.31% | 1.33B |
Medical Supplies
|